{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ-1 gene are associated with recessive, early onset Parkinson’s disease (PD). DJ-1 mutations identified so far are recessive and likely represent loss of function variants.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to loss of function variants of DJ-1, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study measures steady-state protein levels, examines dimer formation, and assesses subcellular localization, which are relevant to understanding the function and stability of DJ-1 in the context of Parkinson’s disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they assess protein stability and function, which are key to the loss of function mechanism in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cycloheximide chase to assess protein stability, co-immunoprecipitation and DSS cross-linking to evaluate dimer formation, and subcellular fractionation to assess localization.",
          "judgment": "Yes",
          "reasoning": "The specific assays used have been broadly accepted historically and are standard techniques in the field of studying protein stability and function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "L166P DJ-1 was barely detectable under similar conditions, indicating drastically reduced protein stability. No dimerized L166P was noted, suggesting that the dimerization of L166P is prevented.",
          "judgment": "Yes",
          "reasoning": "The functional data clearly show a drastic reduction in protein stability and an impairment in dimer formation for the L166P variant, which supports the pathogenicity of this variant.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The L166P variant in DJ-1 shows strong evidence of pathogenicity based on the functional assays, which demonstrate a drastic reduction in protein stability and an impairment in dimer formation, consistent with a loss of function mechanism associated with early onset Parkinson’s disease."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in the DJ-1 gene are associated with recessive, early onset Parkinson’s disease (PD). DJ-1 mutations identified so far are recessive and likely represent loss of function variants.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to loss of function variants of DJ-1, which is relevant to the functional assay being described for this variant."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study measures steady-state protein levels, examines dimer formation, and assesses subcellular localization, which are relevant to understanding the function and stability of DJ-1 in the context of Parkinson’s disease.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model or reflect the disease pathogenesis/mechanism defined in Step 1, as they assess protein stability and function, which are key to the loss of function mechanism in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The paper describes the use of cycloheximide chase to assess protein stability, co-immunoprecipitation and DSS cross-linking to evaluate dimer formation, and subcellular fractionation to assess localization.",
          "judgment": "Yes",
          "reasoning": "The specific assays used have been broadly accepted historically and are standard techniques in the field of studying protein stability and function."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "M26I DJ-1 produced low steady-state protein levels, suggesting that it is also somewhat unstable in the cell, although the effect is less dramatic than that of L166P. A lower intensity V5 M26I DJ-1 band was observed, confirming that M26I can form dimers.",
          "judgment": "Yes",
          "reasoning": "The functional data show a reduction in protein stability and some preservation of dimer formation for the M26I variant, which supports the pathogenicity of this variant but to a lesser extent than L166P.",
          "next_step_or_outcome": "Proceed to determine evidence strength"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The M26I variant in DJ-1 shows supporting evidence of pathogenicity based on the functional assays, which demonstrate a reduction in protein stability and some preservation of dimer formation, consistent with a loss of function mechanism associated with early onset Parkinson’s disease, but with less severity than the L166P variant."
    }
  ]
}